Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Proacta reports data on its novel hypoxia-activated pan-HER inhibitor

Dec. 1, 2009

S*BIO presents its novel, potent dual PI3K/mTOR inhibitor SB-2312

Dec. 1, 2009

Novel 2,3-dioxygenase inhibitor disclosed by Incyte for cancer immunotherapy

Dec. 1, 2009

Preclinical characterization of RP-1040 disclosed at 2009 AACR-NCI-EORTC meeting

Nov. 30, 2009

GW-876008 improves stress-induced rectal hypersensitivity in patients with IBS

Nov. 30, 2009

ICOVIR-17 adenovirus displays enhanced intratumoral distribution and activity in vivo

Nov. 30, 2009

Antimalaria vaccine elicits functional antibodies in phase I trial in malaria-naive subjects

Nov. 30, 2009

Cytokinetics discloses preclinical data on novel smooth muscle myosin inhibitors

Nov. 30, 2009

Aflibercept shows promise in phase II trial in metastatic melanoma patients

Nov. 27, 2009

Promising phase II data on AZD-0837 support further evaluation in AF patients

Nov. 27, 2009

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...